|1.||Willett, Walter C: 2 articles (01/2008 - 09/2005)|
|2.||Clark, Robert Sb: 1 article (02/2015)|
|3.||Skoda, Erin M: 1 article (02/2015)|
|4.||St Croix, Claudette M: 1 article (02/2015)|
|5.||Kochanek, Patrick M: 1 article (02/2015)|
|6.||Anthonymuthu, Tamil S: 1 article (02/2015)|
|7.||Kline, Anthony E: 1 article (02/2015)|
|8.||Baart, Sophie: 1 article (02/2015)|
|9.||Bayır, Hülya: 1 article (02/2015)|
|10.||Tyurina, Yulia Y: 1 article (02/2015)|
01/01/2008 - "Blood levels of trans isomers of oleic and linoleic acids are associated with an increased risk of nonaggressive prostate tumors. "
01/01/2010 - "Furthermore, in men, the risk of tumors decreased significantly as the intake of linoleic acids per body weight increased. "
01/01/2013 - "Brucea javanica oil contains oleic acid and linoleic acids that have been shown by animal and human studies to inhibit tumor formation. "
10/01/1997 - "Results from this laboratory indicate that tumor growth is directly dependent upon increased ambient blood concentrations of arachidonic and linoleic acids, particularly linoleic acid. "
01/01/1995 - "The GLA diet produced some changes in the total fatty acid composition of tumor, plasma and liver of host mice: GLA and arachidonic acid (20:4 n-6, AA) induced significant increases, whereas oleic (18:1 n-9, OA) and linoleic acids (18:2 n-6, LA) were decreased (Table 2). "
|2.||Melanoma (Melanoma, Malignant)
06/01/2005 - "Arachidonic and linoleic acids were the most effective in decreasing the number of viable S91 murine melanoma cells, causing loss of membrane integrity and DNA fragmentation at 100 microM concentration already after 24 h in culture. "
11/01/2011 - "Our findings showed that specific unsatturated fatty acids, such as palmitoleic, oleic and linoleic acids, trigger remarkable phenotypic modifications in a large number of human cancer cell lines (HCCLs), including hepatocarcinoma HUH-7, ovarian carcinoma SK-OV-3, breast adenocarcinoma MCF-7 and melanoma MALME-3M. "
|4.||Juvenile Rheumatoid Arthritis (Juvenile Idiopathic Arthritis)
02/01/2015 - "Here, we report an alternative pathway whereby cereberal ischemia-reperfusion triggered oxygenation of a mitochondria-specific phospholipid, cardiolipin (CL), is followed by its hydrolysis to yield monolyso-CLs and oxygenated derivatives of fatty (linoleic) acids. "
05/01/1990 - "The levels of both saturated and unsaturated NEFA increased during ischemia for 20 min in the working heart but not in the Langendorff heart, although unsaturated NEFA increased in the Langendorff heart when the ischemic period was 40 min. Arachidonic and linoleic acids were the NEFA that accumulated most prominently."
12/06/2002 - "Thapsigargin, an inhibitor of the Ca(2+)-ATPase ER uptake pump, elicited significant elevations in the efflux of myristic, arachidonic and linoleic acids, in the absence of ischemia. "
01/01/1991 - "Addition of arachidonic or linoleic acids to control rat heart mitochondria, inhibits electron transport between Complex I and III. These results are consistent with the following hypothesis: during ischemia, the intracellular energy content drops severely, affecting the cytoplasic concentration of ions such as Na+ and Ca2+. Upon reoxygenation, the mitochondrion is the only organelle capable of eliminating the excess cytoplasmic Ca2+ through an electrogenic process requiring oxygen (the low ATP concentration makes other ATP-dependent Ca2+ transport systems non-operational).(ABSTRACT TRUNCATED AT 250 WORDS)"
01/01/1990 - "Ischemia was produced by lowering the afterload pressure from 60 to 0 mm Hg, and reperfusion resulted from raising the afterload pressure to 60 mm Hg. Ischemia stopped the heart beat, and increased the myocardial levels of unsaturated NEFA (such as arachidonic, palmitoleic, and linoleic acids) as a function of the ischemic period; it decreased the myocardial levels of ATP and CrP, and increased the myocardial level of lactate. "
|4.||Dietary Fats (Ghee)
|5.||Oleic Acid (Oleate)
|6.||Interleukin-6 (Interleukin 6)
|7.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|1.||Heterologous Transplantation (Xenotransplantation)